cytarabine and Carcinoma, Neuroendocrine

cytarabine has been researched along with Carcinoma, Neuroendocrine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campbell, LJ; Ellims, PH; Estey, EH; Juneja, SK; Prince, HM; Seymour, JF	1

Reviews

1 review(s) available for cytarabine and Carcinoma, Neuroendocrine

Article	Year
Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia, 1999, Volume: 13, Issue:11 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome	1999

Article

Year

Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.

Leukemia, 1999, Volume: 13, Issue:11

Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome

1999